TILs in Patients on Trastuzumab/Pertuzumab-Based Chemo TILs in Patients on Trastuzumab/Pertuzumab-Based Chemo

Evaluation of baseline TIL percentage may provide prognostic information to patients receiving dual HER2 blockade for breast cancer.Journal of the National Cancer Institute
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news